Santa Monica, CA, March 06, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the Company appointed Dr. Barry Keenan, Ph.D, MBA, PMP to head up BioSig’s […]
Financial
Le Bonheur Children’s Hospital to expand Heart Institute
MEMPHIS, Tenn., March 5, 2019 /PRNewswire/ — Le Bonheur Children’s Hospital will expand its Heart Institute with a two-story, $37.6 million addition. This expansion will add 19 additional beds to the Heart Institute to create a 31-bed dedicated Cardiovascular Unit. The hospital will expand west to the corner of Poplar Avenue and Dunlap Street. “We […]
CryoLife to Present at Cowen and Company 39th Annual Health Care Conference
ATLANTA, March 5, 2019 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019 at The Boston Marriott Copley Place in Boston. A live webcast of the Company’s presentation is […]
Endologix Announces Approval of Reverse Stock Split
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (the “Company”) (NASDAQ: ELGX) previously announced that a proposal was approved at its Special Meeting of Stockholders, held February 22, 2019, authorizing its Board of Directors to amend the Company’s certificate of incorporation to effect a reverse stock split of the Company’s issued and outstanding shares […]
Corindus to Present at 39th Annual Cowen Health Care Conference on March 13, 2019
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, will present at the 39thAnnual Cowen Health Care Conference as follows: Date: Wednesday, March 13, 2019 Time: 10:40 a.m. Eastern Daylight Time Location: Boston […]
Cardiovascular Systems, Inc. to Present at Three Upcoming Investor Conferences
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will present and host investor meetings at the following three conferences: Cowen 39th Annual Health Care Conference Monday, March […]
MCRA Hires FDA Interventional Cardiology Devices Branch Chief Michael John as VP of Cardiovascular Regulatory Affairs
WASHINGTON, March 5, 2019 /PRNewswire/ — MCRA, LLC, a leading medical device consulting firm and clinical research organization (CRO) that integrates regulatory, clinical research, reimbursement, compliance and quality assurance, is pleased to announce the expansion of its cardiovascular consulting activities through the hiring of Michael C. John, MPH, as its new Vice President […]
Medtronic Announces the Upsizing of its Maximum Tender Offers for Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
DUBLIN – March 4, 2019 – Medtronic plc (the “Company”) (NYSE:MDT) today announced the upsizing of the previously-announced cash tender offers by its wholly-owned subsidiaries, Medtronic, Inc. and Covidien International Finance S.A. (“CIFSA” and, together with Medtronic, Inc., the “Offerors”) for up to $1.9 billion combined aggregate purchase price (excluding accrued […]
Osprey Appoints Mr Jim Surek as Vice President, Sales
March 4, 2019- Minnesota, United States and Melbourne, Australia – Osprey Medical (ASX: OSP) is pleased to announce the appointment of Mr Jim Surek as Vice President, Sales effective from March 1st. Mr Surek brings a wealth of experience and expertise to Osprey. He has over 25 years of senior […]
Dr. Mark Garcia Joins Vesper Medical as Chief Medical Officer
WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a private medical device company developing innovative venous stent solutions for peripheral vascular disease, today announced the appointment of Mark J. Garcia, MD, FSIR, FACR as its Chief Medical Officer. “Dr. Garcia has brought a wealth of clinical experience treating deep venous disease to our Board […]



